Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 3910-3914, November 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levin, W.
Right arrow Articles by Conney, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levin, W.
Right arrow Articles by Conney, A. H.

Exceptionally High Tumor-initiating Activity of Benzo(c)phenanthrene Bay-Region Diol-Epoxides on Mouse Skin

Wayne Levin1, Alexander W. Wood, Richard L. Chang, Yitzhak Ittah, Martine Croisy-Delcey, Haruhiko Yagi, Donald M. Jerina and Allan H. Conney

Department of Biochemistry and Drug Metabolism, Hoffmann-La Roche Inc., Nutley, New Jersey 07110 [W. L., A. W. W., R. L. C., A. H. C.], and Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism, and Digestive Diseases, NIH, Bethesda, Maryland 20205 [Y. I., M. C-D., H. Y., D. M. J.]

Benzo(c)phenanthrene [B(c)Ph], its three metabolically possible trans-dihydrodiols, and the diastereomeric bay-region diol-epoxides derived from trans-3,4-dihydroxy-3,4-dihydrobenzo(c)phenanthrene were tested for tumor-initiating activity on mouse skin. A single topical application of 0.4 or 2.0 µmol of compound was followed seven days later by twice-weekly applications of the tumor promotor 12-O-tetradecanoylphorbol-13-acetate for 20 weeks. B(c)Ph was found to be a weak tumor initiator on mouse skin, producing a 17 to 38% tumor incidence and 0.17 to 0.59 papilloma/mouse at the 0.4- and 2.0-µmol doses, respectively. Of the three metabolically possible trans-dihydrodiols of B(c)Ph, only trans-3,4-dihydroxy-3,4-dihydrobenzo(c)phenanthrene had significant tumor-initiating activity at the doses tested. This compound produced a 28 to 47% tumor incidence and 0.41 to 1.07 tumors/mouse at the 0.4- and 2.0-µmol doses, respectively. Comparisons of the number of papillomas observed per mouse indicated that both diastereomeric 3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo(c)phenanthrenes in which the epoxide oxygen is either cis (diol-epoxide 1) or trans (diol-epoxide 2) to the benzylic 4-hydroxyl group were at least 40-fold more tumorigenic than was the parent hydrocarbon. The bay-region diol-epoxides of B(c)Ph produced 6.5 to 7.0 papillomas/mouse at the 0.4-µmol dose, and the first appearance of tumors was observed as early as six weeks after the beginning of promotion. This is the first example of high tumorigenic activity for a bay-region diol-epoxide 1 diastereomer of a polycyclic aromatic hydrocarbon, and both diastereomeric bay-region diol-epoxides of B(c)Ph are more potent tumor initiators than are the bay-region diol-epoxides derived from benzo(a)pyrene and benzo(a)anthracene. Two model compounds, 1,2-dihydrobenzo(c)phenanthrene and trans-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene, which cannot be metabolized to bay-region diol-epoxides of B(c)Ph, were found to be inactive as tumor initiators on mouse skin. These results support the concept that a bay-region diol-epoxide is a prime candidate for an ultimate carcinogenic metabolite of B(c)Ph.

1 To whom requests for reprints should be addressed.

Received 5/23/80. Accepted 7/17/80.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
V. K. Batra, D. D. Shock, R. Prasad, W. A. Beard, E. W. Hou, L. C. Pedersen, J. M. Sayer, H. Yagi, S. Kumar, D. M. Jerina, et al.
Structure of DNA polymerase beta with a benzo[c]phenanthrene diol epoxide-adducted template exhibits mutagenic features
PNAS, November 14, 2006; 103(46): 17231 - 17236.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Koganti, R. Singh, K. Rozett, N. Modi, L. S. Goldstein, T. A. Roy, F. J. Zhang, R. G. Harvey, and E. H. Weyand
7H-benzo[c]fluorene: a major DNA adduct-forming component of coal tar
Carcinogenesis, August 1, 2000; 21(8): 1601 - 1609.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. E. Smith, M. F. Denissenko, W. P. Bennett, H. Li, S. Amin, M.-s. Tang, and G. P. Pfeifer
Targeting of Lung Cancer Mutational Hotspots by Polycyclic Aromatic Hydrocarbons
J Natl Cancer Inst, May 17, 2000; 92(10): 803 - 811.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.